Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Orchid Pharma
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.11 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
23.71 % | -4.13 % | 41.95 % |
|
5yr average Equity Multiplier
|
1.34 | 1.73 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.45 | 0.89 |
|
5yr Avg Net Profit Margin
|
15.65 % | -7.02 % | 34.6 % |
|
Price to Book
|
7.05 | 3.0 | 15.59 |
|
P/E
|
20.48 | 44.54 | 86.82 |
|
5yr Avg Cash Conversion Cycle
|
-53.67 Days | 49.11 Days | -31.8 Days |
|
Inventory Days
|
61.98 Days | 112.59 Days | 23.52 Days |
|
Days Receivable
|
35.4 Days | 91.49 Days | 48.29 Days |
|
Days Payable
|
143.49 Days | 201.52 Days | 135.34 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | -0.51 | 187.52 |
|
5yr Avg ROCE
|
28.37 % | 0.51 % | 54.74 % |
|
5yr Avg Operating Profit Margin
|
20.94 % | 10.69 % | 45.69 % |
|
5 yr average Debt to Equity
|
0.0 | 0.49 | 0.05 |
|
5yr CAGR Net Profit
|
35.58 % | n/a | 20.11 % |
|
5yr Average Return on Assets
|
17.85 % | -1.77 % | 30.29 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 69.84 % | 70.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.54 % | -20.12 % | -4.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.38 % | 16.13 % | 1.14 % |
|
RPG Life Sciences
|
Orchid Pharma
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|